Fibroblast growth factor 2: from laboratory evidence to clinical application.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 15320831)

Published in Curr Vasc Pharmacol on January 01, 2004

Authors

Chu-Huang Chen1, Simon M Poucher, Jonathan Lu, Philip D Henry

Author Affiliations

1: Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. cchen@bcm.tmc.edu

Articles citing this

Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol (2007) 1.17

Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol (2006) 1.12

Rough titanium alloys regulate osteoblast production of angiogenic factors. Spine J (2013) 0.95

Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med (2011) 0.91

Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance. Exp Cell Res (2013) 0.86

The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy. PLoS One (2014) 0.82

Generating elastin-rich small intestinal submucosa-based smooth muscle constructs utilizing exogenous growth factors and cyclic mechanical stimulation. Tissue Eng Part A (2009) 0.81

Comparison between Culture Conditions Improving Growth and Differentiation of Blood and Bone Marrow Cells Committed to the Endothelial Cell Lineage. Biol Proced Online (2010) 0.80

Retracted Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice. Clin Sci (Lond) (2012) 0.77

Biodegradable photo-crosslinked alginate nanofibre scaffolds with tuneable physical properties, cell adhesivity and growth factor release. Eur Cell Mater (2012) 0.76

Ultrastructural immunolocalization of basic fibroblast growth factor in endothelial cells: morphologic evidence for unconventional secretion of a novel protein. J Mol Histol (2011) 0.75

Articles by these authors

BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development (2004) 2.50

Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases. Toxicol Pathol (2010) 1.45

Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation (2003) 1.12

Biophysical properties of slow potassium channels in human embryonic stem cell derived cardiomyocytes implicate subunit stoichiometry. J Physiol (2011) 1.08

Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time. Pacing Clin Electrophysiol (2008) 1.07

Multi-channel microstrip transceiver arrays using harmonics for high field MR imaging in humans. IEEE Trans Med Imaging (2011) 1.02

Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood (2013) 1.00

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs (2013) 0.99

Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J Lipid Res (2007) 0.96

Flexible transceiver array for ultrahigh field human MR imaging. Magn Reson Med (2012) 0.95

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2012) 0.95

The intravenous glucose tolerance test in cannulated Wistar rats: a robust method for the in vivo assessment of glucose-stimulated insulin secretion. J Pharmacol Toxicol Methods (2008) 0.94

Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovasc Res (2013) 0.90

Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor. PLoS One (2013) 0.88

Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats. J Endocrinol (2011) 0.87

The acetyl group deficit at the onset of contraction in ischaemic canine skeletal muscle. J Physiol (2002) 0.87

Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction. J Physiol (2004) 0.87

The glycogenic action of protein targeting to glycogen in hepatocytes involves multiple mechanisms including phosphorylase inactivation and glycogen synthase translocation. J Biol Chem (2004) 0.86

Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle. Am J Physiol Endocrinol Metab (2004) 0.85

Single dose glucagon (0.5 mg IV bolus) administration in healthy human volunteers is a robust model for assessment of glycogenolysis: characterisation of the glucose excursion after glucagon challenge. J Pharmacol Toxicol Methods (2006) 0.84

Structural pathways and prevention of heart failure and sudden death. J Cardiovasc Electrophysiol (2003) 0.83

Manganese enhancement in non-CNS organs. NMR Biomed (2010) 0.83

Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin. Postgrad Med (2012) 0.81

Effects of electronegative VLDL on endothelium damage in metabolic syndrome. Diabetes Care (2012) 0.80

Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein. Pure Appl Chem (2011) 0.80

Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses (2010) 0.80

The temporal relationship between glycogen phosphorylase and activation of the pyruvate dehydrogenase complex during adrenaline infusion in resting canine skeletal muscle. J Physiol (2002) 0.78

Spontaneous coronary artery dissection in a woman on fenfluramine. Rev Cardiovasc Med (2007) 0.77

Glucagon challenge in the rat: a robust method for the in vivo assessment of Glycogen phosphorlyase inhibitor efficacy. J Pharmacol Toxicol Methods (2006) 0.77

Increased sensitivity of glycogen synthesis to phosphorylase-a and impaired expression of the glycogen-targeting protein R6 in hepatocytes from insulin-resistant Zucker fa/fa rats. FEBS J (2006) 0.77

Reversibility of hyperglycaemia and islet abnormalities in the high fat-fed female ZDF rat model of type 2 diabetes. J Pharmacol Toxicol Methods (2010) 0.77

Ablation for atrial fibrillation: are cures really achieved? J Am Coll Cardiol (2004) 0.76

Acute Traumatic Wound Management in the Prolonged Field Care Setting. J Spec Oper Med (2017) 0.75

Direct Two-Minute Unassisted Breathing Evaluation (DTUBE) Is an Attractive Alternative to Longer Spontaneous Breathing Trials: A Prospective Observational Study. Am Surg (2017) 0.75

Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model. J Vasc Res (2017) 0.75

Bicarbonate-induced alkalosis augments cellular acetyl group availability and isometric force during the rest-to-work transition in canine skeletal muscle. Exp Physiol (2002) 0.75

Class I or class III agents for atrial fibrillation: are asking the right question? Pacing Clin Electrophysiol (2003) 0.75